Maeda Shingo

マエダシンゴ | Maeda Shingo

Affiliation and department：
Homepage URL (1)： https://www.maedalab.com

Research field (3)： Immunology , Molecular biology , Veterinary medicine

Research keywords (9)：多発性嚢胞腎 , 慢性腎臓病 , Regulatory T cell , Allergy , Protease , Gastroenterology , Urology , Immunology , Cancer

Research theme for competitive and other funds (11)：

2024 - 2029 Elucidation of the pathogenesis of idiopathic epilepsy in dogs based on lipid metabolic profiles and establishment of treatment methods
2023 - 2028 翻訳開始因子DAP5を軸とした腎糸球体障害の病態理解と応用
2024 - 2027 Drug discovery of feline chronic kidney disease by targeting feline senesce-associated T cells
2021 - 2024 The mechanism of microstructural damage of the proximal tubule of the kidney caused by oxidative stress
2019 - 2024 腎糸球体障害における凝固因子・内皮細胞・ポドサイトのクロストーク機構の解明

Show all

Papers (91)：

Yosuke Takahashi, Daiki Kato, Shingo Maeda, Tomoki Motegi, Atsushi Fujita, Yuko Hashimoto, Takayuki Nakagawa, Ryohei Nishimura. Outcomes of total cystectomy with medical treatment in canine urothelial carcinoma of the bladder trigone. The Canadian veterinary journal = La revue veterinaire canadienne. 2025. 66. 3. 318-326
Kenjiro Kaji, Tomoki Motegi, Tomohiro Yonezawa, Yasuyuki Momoi, Shingo Maeda. Anti-tumour effects of lapatinib on HER2-positive canine prostatic carcinoma cell lines. Open veterinary journal. 2024. 14. 5. 1259-1268
Shohei Yokota, Tomohiro Yonezawa, Yasuyuki Momoi, Shingo Maeda. Myeloid derived suppressor cells in peripheral blood can be a prognostic factor in canine transitional cell carcinoma. Veterinary immunology and immunopathology. 2024. 269. 110716-110716
Shiori Sato, Koji Hori, Gaku Tanabe, Shingo Maeda, Yasuyuki Momoi, Tomohiro Yonezawa. Effect of diazoxide on a cat with insulinoma. JFMS open reports. 2024. 10. 1. 20551169231220290-20551169231220290
Maho Nakazawa, Ryota Tochinai, Wataru Fujii, Mao Komori, Tomohiro Yonezawa, Yasuyuki Momoi, Shingo Maeda. Protective role of protease-activated receptor-2 in anaphylaxis model mice. PloS one. 2024. 19. 4. e0283915

ｍore...

MISC (69)：

前田真吾. 制御性T細胞を制御する(第6回) 制御性T細胞を減弱する治療戦略. Veterinary Immunology for Practitioners. 2024. 9. 4. 3-10
前田真吾. 制御性T細胞を制御する(第5回) 制御性T細胞を増強する治療戦略. Veterinary Immunology for Practitioners. 2024. 9. 3. 34-37
前田真吾. 制御性T細胞を制御する(第4回) 制御性T細胞と疾患. Veterinary Immunology for Practitioners. 2024. 9. 2. 26-33
堀田康介, 米澤智洋, 桃井康行, 前田真吾. ラパチニブを投与されたイヌの尿路上皮癌症例における皮膚有害事象の回顧的研究. 日本獣医皮膚科学会学術大会・総会. 2024. 27th
前田真吾. 制御性T細胞を制御する(第3回) 制御性T細胞の免疫抑制メカニズム. Veterinary Immunology for Practitioners. 2024. 9. 1. 28-34

ｍore...

Patents (5)：

Lectures and oral presentations (18)：

Translational research on the development of novel immunotherapy using a canine model of spontaneous cancer
(The 23rd Federation of Asian Veterinary Associations Congress (FAVA 2024) 2024)
Second era of molecular-targeted cancer therapies in dogs
(The 23rd Federation of Asian Veterinary Associations Congress (FAVA 2024) 2024)
Lapatinib Therapy in Canine Urothelial Carcinoma: From Molecular Insights to Clinical Outcomes
(ACVIM ACE 2024)
イヌの尿路上皮癌に対する内科療法の最前線
(第16回日本獣医腎泌尿器学会学術集会・総会 2024)
がんの自然発症動物モデルとして「イヌ」を用いたComparative Oncology
(日本患者由来がんモデル学会・日本ヒト細胞学会合同学術集会2024 2024)

ｍore...

Education (2)：

Work history (5)：

Committee career (3)：

Awards (3)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page